The stock price of Medigus Ltd (MDGS) closed the recent trading session at $1.18, 4.84% less than the previous trading session. The stock kept oscillating between $1.15 and $1.25 during the recent trading session. In the after-hours, the stock of MDGS gained 0.86%, to $1.19.
Medigus Ltd is a technology company centered around growth partnerships, predominately in the field of advanced medical solutions, the market of electric vehicles, and E-commerce. MDGS was founded in 1999 and is based in Israel. The company has a market capitalization of $28.14 million.
MDGS News
On February 8, 2022, MDGS announced the signing of an investment agreement with a medical company, Clearmind Medicine Inc. According to the agreement signed, MDGS will invest $1.25 million in 2 million shares and warrants of Clearmind medicine. As a feature of the arrangement, Medigus will be given around 2 million units of Clearmind Medicine Inc, including one share of the normal stock and one warrant, at a cost of $0.63 per unit. The exercisable time for each warrant will be 18 months. An investment amount of $0.75 million will be paid for in the cash and $0.50 million will be paid through the issuance of MDGS share, at a cost of $1.20.
Also, Medigus will be qualified for 10% of the underlying equity of an expected endeavor in the space of psychedelics, regarding an examination project at present, directed by an agreement among Clearmind and the commercialization arm of an Israeli educational institute.
In another news, On February 4, 2022, MDGS announced that it has bought around 40% of an Israeli drone technology organization with a patented safety framework for the drones. This Israeli-drone company has fostered licensed drone security and safety framework which is intended to safeguard individuals and payloads, giving a solution to lessen the risk of a drone’s conceivable breakdown in an urban environment. The investment is steady with Medigus’ main goal to catch early phase organizations, transforming them into important resources by streamlining assets and making a critical investor value.
CEO Remarks
The Chief Executive Officer of Medigus Ltd, Liron Carmel, said that they are excited about the acquisition of a large percentage in the drone company. He added that in his belief the technology of this company is a game-changer in the drone industry.
Mr. Carmel concluded his remarks by saying that this agreement is a great win for MDGS.
